CHEK 1 (-7.41%)
IL0011336851Medical Diagnostics & ResearchDiagnostics & Research

Check-Cap (CHEK) Competitor Comparison

We are evaluating the key criteria listed to compare Check-Cap (CHEK) against its competitors in the Diagnostics & Research industry.

Piotroski Rank - CHEK ranking 0 / 58

These are the competitors of Check-Cap in the industry Diagnostics & Research ranked by piotroski rank
1. Syneos Health SYNH
0.89
2. Danaher DHR
0.89
3. PerkinElmer PKI
0.89
4. IQVIA Holdings IQV
0.78
5. Charles River Laboratories CRL
0.78
6. Icon ICLR
0.78
7. Medpace Holdings MEDP
0.78
8. Lantheus Holdings LNTH
0.78
9. Agilent Technologies A
0.67
10. Qiagen QGEN
0.67
11. Global Cord Blood CO
0.67
12. DexCom DXCM
0.67
13. National Research NRC
0.67
14. bioAffinity Technologies BIAF
0.67
15. Mettler-Toledo MTD
0.67
16. Prenetics Global PRE
0.67
17. Neogen NEOG
0.56
18. Ortho Clinical Diagnostics Holdings OCDX
0.56
19. Thermo Fisher Scientific TMO
0.56
20. Anixa Biosciences ANIX
0.56
21. IDEXX Laboratories IDXX
0.56
22. Interpace Biosciences IDXG
0.56
23. Laboratory Corp of America Holdings LH
0.56
24. Olink Holding OLK
0.44
25. Fulgent Genetics FLGT
0.44
26. Twist Bioscience TWST
0.44
27. DarioHealth DRIO
0.44
28. RadNet RDNT
0.44
29. MDxHealth MDXH
0.44
30. Aspira Womens Health AWH
0.44
31. Meridian Bioscience VIVO
0.44
32. Psychemedics PMD
0.44
33. Quest Diagnostics DGX
0.44
34. Natera NTRA
0.44
35. Sotera Health SHC
0.44
36. Waters WAT
0.44
37. SeqLL SQL
0.33
38. Biodesix BDSX
0.33
39. Co-Diagnostics CODX
0.33
40. Exact Sciences EXAS
0.33
41. Guardant Health GH
0.33
42. Inotiv NOTV
0.33
43. Neuronetics STIM
0.33
44. Organovo Holdings ONVO
0.33
45. Sera Prognostics SERA
0.33
46. Heska HSKA
0.22
47. MaxCyte MXCT
0.22
48. Illumina ILMN
0.22
49. Trinity Biotech TRIB
0.22
50. Myriad Genetics MYGN
0.22
51. Precipio PRPO
0.22
52. CareDx CDNA
0.11
53. Bioventus BVS
0.11
54. Pacific Biosciences of California PACB
0.11
55. NeoGenomics NEO
0.11
56. Personalis PSNL
0.11
57. Exagen XGN
0.11
58. Enzo Biochem ENZ
0.11

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.